Revenue

Administer's revenue growth in the last quarter has been driven by a significant increase in net sales, which rose by 62.6% compared to the same period in the previous year. This surge can be attributed to the company's efforts to expand its customer base and increase market share, as evident from the notable growth in net sales in the second quarter. However, the revenue growth has been somewhat tempered by the loss-making operations of Sarastia, which has impacted the company's overall performance. Despite this, Administer's management is optimistic about the future, citing the company's strong market position and ability to adapt to changing market conditions. As the company continues to navigate the challenges of the market, it is likely that revenue growth will remain a key focus area, with Administer seeking to build on its recent momentum and drive further expansion.

The realised revenue for Q2 2026 is 31.2 million Euros, while the predicted revenue for Q2 2027 (e) is 30.1 million Euros. The revenue is expected to decrease by 0.1 million Euros, which is a 0.32% decrease. The change in Administer Revenue from 2025 to 2026 is 31.7 million Euros, representing a 43.2% increase. From 2026 to 2027, the change is 7.3 million Euros, a 6.9% increase. The annual Revenue values are 73.3 million Euros in 2025, 105.0 million Euros in 2026, and 113.0 million Euros in 2027.

Ebit

Administer's EBIT profitability has experienced a significant decline, with a notable drop in the second quarter of 2026. This downturn can be attributed to the company's acquisition-related costs and restructuring expenses, which have weighed heavily on its profitability. Furthermore, the loss-making operations of Sarastia have also contributed to the decline in EBIT profitability. Despite efforts to improve profitability, Administer's EBIT remains under pressure, indicating a need for further cost optimization and operational adjustments. The company's ability to manage these costs and drive profitability will be crucial in its future performance.

The realised Ebit for Q2 2026 is -0.3 million Euros, while the predicted Ebit for Q2 2027 (e) is -0.2 million Euros. The expected change in Ebit from Q2 2026 to Q2 2027 (e) is an increase of 0.1 million Euros, which represents a 33.3% improvement. The change in Ebit from 2025 to 2026 is an increase of 0.2 million Euros, which is a 66.7% change. The change in Ebit from 2026 to 2027 is an increase of 0.2 million Euros, which is a 66.7% change. The annual Ebit values are -0.3 million Euros in 2025, -0.1 million Euros in 2026, and 0.1 million Euros in 2027.

Profit befor tax

The realised value of Profit before tax in Q2 2026 is -0.6 million Euros, while the predicted value for Q2 2027 (e) is -0.4 million Euros. This represents a decrease of 0.2 million Euros, or a 33.3% reduction, in one year. The change in Profit before tax from 2025 to 2026 is expected to be a decrease of 0.1 million Euros, which is a 10% decrease. From 2026 to 2027, the expected change is a decrease of 0.4 million Euros, which is a 36.4% decrease. The annual values for Profit before tax are -1.0 million Euros in 2025, -1.1 million Euros in 2026, and -0.7 million Euros in 2027.

Profit

The realised profit for Q2 2026 is -0.8 million Euros, while the predicted profit for Q2 2027 (e) is -0.3 million Euros. The expected change in profit from Q2 2026 to Q2 2027 (e) is an increase of 0.5 million Euros, which represents a 62.5% improvement. The change in Administer Profit from 2025 to 2026 is expected to be a decrease of 0.3 million Euros, which is a 18.75% reduction. From 2026 to 2027, the expected change is a decrease of 0.7 million Euros, which is a 53.85% reduction. The annual values for Profit are -1.6 million Euros in 2025, -1.3 million Euros in 2026, and -0.6 million Euros in 2027.